Psychopharmacological treatments have not only proven to be valuable but sometimes indispensable in the management of paraphilic sexual offenders. Despite not being approved by the FDA, some medications commonly used in paraphilic outpatients, such as Medroxyprogesterone and Leuprolide Acetate, cannot be considered an experimental or investigative medical procedure. Unfortunately, in Brazil, the use of hormonal medications for the treatment of dangerous sexual offenders has been seen as amoral and insufficiently effective and safe. This position creates many difficulties in the adequate management of sexual offenders in our country.
Get full access to this article
View all access options for this article.
References
1.
AbbeyA.Clinton-SherrodA.M.McAuslanP.ZawackiT.BuckP.O.2003. The relationship between the quantity of alcohol consumed and the severity of sexual assaults committed by college men. Journal of Interpersonal Violence., 18: 813–833.
2.
AllnuttS.H.BradfordJ.M.GreenbergD.M.CurryS.1996. Co-morbidity of alcoholism and the paraphilias. Journal of Forensic Sciences., 41: 234–239.
3.
American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders, , 4th ed., text revision, Washington, DC: Author.
4.
American Psychiatric Association (APA). 1999. Dangerous sex offenders. A task force report of the American Psychiatric Association, Washington, DC: Author.
5.
AppelbaumP.S.GutheilT.G.2007. Clinical handbook of psychiatry & the law, 1–32. Philadelphia: Lippincott Williams & Wilkins.
6.
BaltieriD.A.De AndradeA.G.2006. “Alcohol and drug consumption and sexual impulsivity among sexual offenders”. In New research on alcohol abuse and alcoholism, Edited by: BroznerE.Y.133–154. New York: Nova Science Publishers.
7.
BaltieriD.A.De AndradeA.G.2008. Alcohol and drug consumption among sexual offenders. Forensic Science International., 175: 31–35.
8.
BlanchardR.KollaN.J.CantorJ.M.KlassenP.E.DickeyR.KubanM.E.2007. IQ, handedness, and pedophilia in adult male patients stratified by referral source. Sex Abuse: a Journal of Research and Treatment., 19: 285–309.
9.
BradfordJ.HarrisV.L.2003. “Psychopharmacological treatment of sex offenders”. In Principles and practice of forensic psychiatry, Edited by: RosnerR.685–699. London: Arnold.
10.
BrikenP.KafkaM.P.2007. Pharmacological treatments for paraphilic patients and sexual offenders. Current Opinion in Psychiatry., 20: 609–613.
11.
BurnsJ.M.SwerdlowR.H.2003. Right orbitofrontal tumor with pedophilia symptom and constructional apraxia sign. Archives of Neurology., 60: 437–440.
12.
CantorJ.M.BlanchardR.ChristensenB.K.DickeyR.KlassenP.E.BecksteadA.L.2004. Intelligence, memory, and handedness in pedophilia. Neuropsychology., 18: 3–14.
13.
CantorJ.M.KabaniN.ChristensenB.K.ZipurskyR.B.BarbareeH.E.DickeyR.2008. Cerebral white matter deficiencies in pedophilic men. Journal of Psychiatric Research., 42: 167–183.
14.
ChowE.W.ChoyA.L.2002. Clinical characteristics and treatment response to SSRI in a female pedophile. Archives of Sexual Behavior, 31: 211–215.
15.
CloningerC.R.1996. “Assessment of the impulsive-compulsive spectrum of behavior by the seven-factor model of temperament and character”. In Impulsivity and compulsivity, Edited by: OldhamJ.M.HollanderE.SkodolA.E.59–98. Washington, DC: American Psychiatric Press.
FaganP.J.WiseT.N.SchmidtC.W.Jr.BerlinF.S.2002. Pedophilia. The Journal of the American Medical Association., 288: 2458–2465.
18.
FuentesD.TavaresH.CamargoC.H. P.GorensteinC.2000. “Inventário de temperamento e caráter de Cloninger—validação e versão em Português”. In Escalas de Avaliação em Psiquiatria e Psicofarmacologia, Edited by: GorensteinC.AndradeL.H. S. G.ZuardiA.W.363–376. São Paulo: Lemos.
19.
GaffneyG.R.BerlinF.S.1984. Is there hypothalamic-pituitary-gonadal dysfunction in paedophilia? A pilot study. British Journal of Psychiatry., 145: 657–660.
20.
HallR.C.2007. A profile of pedophilia: definition, characteristics of offenders, recidivism, treatment outcomes, and forensic issues. Mayo Clinic Proceedings., 82: 457–471.
21.
HansonR.K.MortonK.E.HarrisA.J.2003. Sexual offender recidivism risk: what we know and what we need to know. Annals of the New York Academy of Sciences, 989: 154–166.
22.
HarrisonK.2007. The high-risk sex offender strategy in England and Wales: is chemical castration an option?. The Howard Journal, 46: 16–31.
23.
HillA.BrikenP.KrausC.StrohmK.BernerW.2003. Differential pharmacological treatment of paraphilias and sex offenders. International Journal of Offender Therapy & Comparative Criminology., 47: 407–421.
24.
JesusD.E.2001. Lei das Contravenções Penais Anotada, 218–220. São Paulo: Saraiva.
25.
KafkaM.P.HennenJ.2002. Hypersexual desire in males: are males with paraphilias different from males with paraphilia-related disorders?. Sexual Abuse: A journal of Research and Treatment, 15: 307–321.
26.
KatzD.A.1999. “Psychopharmacological interventions with adolescent and adult sex offenders”. In Sexual aggression, Edited by: ShawJ.A.305–326. Washington, DC: American Psychiatric Press.
27.
KravitzH.M.HaywoodT.W.KellyJ.WahlstromC.LilesS.CavanaughJ.L.Jr.1995. Medroxyprogesterone treatment for paraphiliacs. The Bulletin of the American Academy of Psychiatry and the Law., 23: 19–33.
28.
MaesM.van WestD.De VosN.WestenbergH.Van HunselF.HendriksD.2001. Lower baseline plasma cortisol and prolactin together with increased body temperature and higher mCPP-induced cortisol responses in men with pedophilia. Neuropsychopharmacology., 24: 37–46.
29.
MendezM.F.ChowT.RingmanJ.TwitchellG.HinkinC.H.2000. Pedophilia and temporal lobe disturbances. Journal of Neuropsychiatry Clinical and Neuroscience., 12: 71–76.
30.
MurrayJ.B.2000. Psychological profile of pedophiles and child molesters. Jounal of Psychology., 134: 211–224.
31.
NunesC.H. S. S.HutzC.S.2001. Escala Fatorial de Ajustamento Emocional / Neuroticismo, São Paulo: Casa do Psicólogo.
32.
O Estado de São Paulo. 2007. ‘Ambulatório do ABC realiza ‘Castração Química’ de Pedófilos’. 16 October 2007: 1
33.
QuinseyV.L.HarrisG.T.RiceM.E.CormierC.A.2003. Violent Offenders. Appraising and Managing Risk, Washington, DC: American Psychological Association.
34.
RaymondN.C.ColemanE.OhlerkingF.ChristensonG.A.MinerM.1999. Psychiatric comorbidity in pedophilic sex offenders. American Journal of Psychiatry., 156: 786–788.
35.
ReillyD.R.DelvaN.J.HudsonR.W.2000. Protocols for the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia. Canadian Journal of Psychiatry., 45: 559–563.
36.
SalehF.M.BerlinF.S.2003. “Sex hormones, neurotransmitters, and psychopharmacological treatments in men with paraphilic disorders”. In Identifying and treating sex offenders: Current approaches, research, and techniques, Edited by: GeffnerR.FraneyK.C.ArnoldT.G.FalconerR.233–253. New York: The Haworth Press.
37.
SalehF.M.NielT.FishmanM.J.2004. Treatment of paraphilia in young adults with leuprolide acetate: a preliminary case report series. Journal of Forensic Science., 49: 1343–1348.
38.
SchifferB.PeschelT.PaulT.GizewskiE.ForstingM.LeygrafN.2007. Structural brain abnormalities in the frontostriatal system and cerebellum in pedophilia. Journal of Psychiatric Research., 41: 753–762.
39.
SchiltzK.WitzelJ.NorthoffG.ZierhutK.GubkaU.FellmannH.2007. Brain pathology in pedophilic offenders: evidence of volume reduction in the right amygdala and related diencephalic structures. Archives of General Psychiatry., 64: 737–746.
40.
StompeT.2007. [Drug-therapy with sexual offenders]. Neuropsychiatry., 21: 12–17.
41.
TestaM.2002. The impact of men's alcohol consumption on perpetration of sexual aggression. Clinical Psychology Review., 22: 1239–1263.
42.
UllmanS.E.BrecklinL.R.2000. Alcohol and adult sexual assault in a national sample of women. Journal of Substance Abuse., 11: 405–420.
43.
World Health Organization. 1992. Classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines, Geneva: Author. The ICD-10
